These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Influence of the immunostimulating substance tiprotimod on Candida albicans infection in relation to activation of macrophages. Dickneite G; Schorlemmer HU; Sedlacek HH Int J Immunopharmacol; 1989; 11(8):895-903. PubMed ID: 2482261 [TBL] [Abstract][Full Text] [Related]
4. Influence of leflunomide on gastrointestinal Candida albicans infection induced in naive and arthritic newborn mice. Dimitrova P; Ivanovska N Int Immunopharmacol; 2006 Nov; 6(11):1682-9. PubMed ID: 16979122 [TBL] [Abstract][Full Text] [Related]
5. Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice. Khan MA; Nasti TH; Saima K; Mallick AI; Firoz A; Wajahul H; Ahmad N; Mohammad O FEMS Immunol Med Microbiol; 2004 Jul; 41(3):249-58. PubMed ID: 15196575 [TBL] [Abstract][Full Text] [Related]
6. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems. Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322 [TBL] [Abstract][Full Text] [Related]
8. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice. Khan MA; Khan A; Owais M FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598 [TBL] [Abstract][Full Text] [Related]
9. Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene. Doyle TC; Nawotka KA; Kawahara CB; Francis KP; Contag PR Microb Pathog; 2006 Feb; 40(2):82-90. PubMed ID: 16426810 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow colony-formation in vitro after infection of genetically defined inbred mice with Candida albicans. Wanasaengsakul S; Ashman RB Microb Pathog; 2004 Apr; 36(4):211-7. PubMed ID: 15001227 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of pseudohyphal growth as a neutrophil-mediated host defense mechanism against experimental deep Candida albicans infections in mice. Sohnle PG; Hahn BL J Lab Clin Med; 1993 Feb; 121(2):235-43. PubMed ID: 8433039 [TBL] [Abstract][Full Text] [Related]
12. Role of adaptive immunity in the pathogenesis of Candida albicans keratitis. Zhang H; Chen H; Niu J; Wang Y; Xie L Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2653-9. PubMed ID: 19218608 [TBL] [Abstract][Full Text] [Related]
13. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis. Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477 [TBL] [Abstract][Full Text] [Related]
14. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma. Kalland T Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041 [TBL] [Abstract][Full Text] [Related]
15. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis. Warn PA; Sharp A; Morrissey G; Denning DW J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462 [TBL] [Abstract][Full Text] [Related]
16. Sleep and temperature responses of inbred mice with Candida albicans-induced pyelonephritis. Toth LA; Hughes LF Comp Med; 2006 Aug; 56(4):252-61. PubMed ID: 16941952 [TBL] [Abstract][Full Text] [Related]
17. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. MacCallum DM; Odds FC Mycoses; 2005 May; 48(3):151-61. PubMed ID: 15842329 [TBL] [Abstract][Full Text] [Related]
18. Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice. Hida S; Miura NN; Adachi Y; Ohno N J Autoimmun; 2005 Sep; 25(2):93-101. PubMed ID: 16242302 [TBL] [Abstract][Full Text] [Related]
19. LAAE-14, a new anti-inflammatory drug, increases the survival of Candida albicans-inoculated mice. Lucas R; Villamón E; Payá M; Alves M; del Olmo E; Gozalbo D; Gil ML FEMS Immunol Med Microbiol; 2004 Apr; 40(3):239-42. PubMed ID: 15039100 [TBL] [Abstract][Full Text] [Related]
20. Host resistance to Candida albicans infection of mice with collagen-induced arthritis treated with leflunomide. Dimitrova P; Ivanovska N Res Microbiol; 2006; 157(6):525-30. PubMed ID: 16797932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]